Company Performance: Strong revenue growth, profitability, and positive earnings reports typically drive the stock price higher. Conversely, declining sales, losses, and negative earnings can push the price lower.

Industry Trends: Overall health and outlook of the biotechnology industry affect investor sentiment towards NOVA.US. Positive trends like new drug approvals and increasing healthcare spending can be beneficial.

Regulatory Environment: Changes in regulations related to drug development, approval processes, and pricing can significantly impact NOVA.US. Stringent regulations may negatively affect stock price.

Clinical Trial Results: Positive outcomes from clinical trials of NOVA's drug candidates generally lead to price increases. Failure or delays in clinical trials can cause the stock price to decline.

Market Sentiment: General investor confidence and risk appetite play a role. During periods of market optimism, investors may be more willing to invest in growth stocks like NOVA.US.

Competition: Presence of strong competitors and their actions affect NOVA.US. Successful product launches by competitors or competitive pricing pressures can negatively impact NOVA's stock price.